Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BZYQT on Allergic Rhinitis
NCT03033290Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buzhong yiqi in allergic rhinitis (AR), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
buzhong yiqi
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT03033290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033290.